/

Other

/

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc.

Verified Nov 2026

Other

·

United States flag

Rockville, Maryland

·

Since 2005

Supernus Pharmaceuticals is a biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland, with 500-1,000 employees and estimated revenue of $500M-1B. It develops and commercializes treatments for central nervous system disorders including opioid use disorder, ADHD, Parkinson's disease, postpartum depression, epilepsy, and migraine. In November 2026, Supernus completed a merger with Indivior to create a diversified CNS biopharmaceutical company.

Supernus Pharmaceuticals, Inc.

Verified Nov 2026

AT A GLANCE

Founded

2005

Headquarters

United States flag

Rockville, Maryland

Employees

500-1,000

Ownership

Supernus Pharmaceuticals, Inc. at a glance

Revenue

$500M-1B

Est. band

Employees

500-1,000

Founded

2005

Headquarters

Rockville, Maryland

Industries

Automotive

Electric Vehicles

Medical

Overview

Supernus Pharmaceuticals is a biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland, with 500-1,000 employees and estimated revenue of $500M-1B. It develops and commercializes treatments for central nervous system disorders including opioid use disorder, ADHD, Parkinson's disease, postpartum depression, epilepsy, and migraine. In November 2026, Supernus completed a merger with Indivior to create a diversified CNS biopharmaceutical company.

At a glance

Attribute

Detail

Founded

2005

Headquarters

Rockville, Maryland

Employees

500-1,000

Revenue

$500M-1B (estimated)

What Supernus Pharmaceuticals, Inc. makes

The company's portfolio includes approved treatments for multiple CNS conditions and employs proprietary platforms such as an apomorphine infusion device and extended-release formulations.

Latest developments

Company details

Supernus serves the medical and pharmaceutical manufacturing sectors with a commercial portfolio spanning neurology and psychiatry indications. Supernus Pharmaceuticals, Inc. was founded in 2005, has an estimated 500-1,000 employees, and is headquartered in Rockville, Maryland.

Frequently asked questions

What does Supernus Pharmaceuticals, Inc. do?

Supernus Pharmaceuticals is a biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland, with 500-1,000 employees and estimated revenue of $500M-1B. It develops and commercializes treatments for central nervous system disorders including opioid use disorder, ADHD, Parkinson's disease, postpartum depression, epilepsy, and migraine. In November 2026, Supernus completed a merger with Indivior to create a diversified CNS biopharmaceutical company.

Where is Supernus Pharmaceuticals, Inc. headquartered?

Supernus Pharmaceuticals, Inc. is headquartered in Rockville, Maryland (9715 Key West Avenue, Rockville, Maryland, 20850).

When was Supernus Pharmaceuticals, Inc. founded?

Supernus Pharmaceuticals, Inc. was founded in 2005.

How big is Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. has an estimated 500-1,000 employees, with revenue in the $500M-1B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Rockville, Maryland (HQ)Headquarters · United States
Rockville, Maryland (HQ)9715 Key West Avenue, Rockville, Maryland, 20850, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.